Should I Buy ZBH Stock in 2026?

Data-driven analysis and honest assessment for Zimmer Biomet Holdings Inc

Analysis Updated:
CAUTIONSeveral concerns warrant careful consideration

Current Price: $98.44P/E: 28.4

Decision Score

5.2/10

Hold

Based on 6 fundamental factors

Score Breakdown:

Valuation (20%)5/10

Elevated P/E of 28.4

Growth (20%)3/10

Declining -0%

Profitability (20%)4/10

Thin margins (0% net)

Financial Health (15%)5/10

Financial health data limited

Cash Flow (15%)10/10

Excellent FCF yield of 8.7%

Insider Activity (10%)5/10

No recent insider activity

Key Investment Metrics

Current Price

$98.44

P/E Ratio

28.45

Revenue Growth

0.1%

Profit Margin

0.1%

Market Cap

$20.0B

Dividend Yield

0.01%

How ZBH Compares to Competitors

Understanding how ZBH stacks up against peers helps inform your investment decision.

How ZBH Compares to Peers

Upcoming Events for ZBH

+5 Reasons TO Buy ZBH

1. High free cash flow yield of 8.7%

strong

FCF yield above 5% means substantial cash generation for dividends, buybacks, or reinvestment.

2. High gross margins of 70%

moderate

Gross margins above 50% typically indicate strong brand value or intellectual property moats.

-5 Reasons NOT to Buy ZBH

1. Thin profit margins of 0.1%

high risk

Low margins provide little cushion against cost increases or pricing pressure.

2. Minimal revenue growth

low risk

Growth of 0.1% barely keeps pace with inflation.

Who Should Buy ZBH?

Investment Profile

Risk Level

Medium

Recommended Holding Period

3-5 years

Best For:

    Not Suitable For:

    • Growth Investors

      Limited 0% growth may disappoint

    • Income-Focused Retirees

      Low 0.0% yield

    Consider These Alternatives

    If you're interested in ZBH, compare these Health Care peers:

    Pro tip: Compare ZBH directly with competitors using our comparison tool to see which stock better fits your criteria.

    Get the Full Picture

    Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for ZBH

    Frequently Asked Questions

    What is ZBH stock price today?

    ZBH (Zimmer Biomet Holdings Inc) stock is trading at $98.44 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

    Is ZBH stock going up or down today?

    ZBH stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

    Should I buy ZBH stock now?

    The decision to buy ZBH depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

    Is ZBH a buy, hold, or sell right now?

    Our AI-powered analysis provides buy/hold/sell recommendations for ZBH based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

    Is ZBH stock overvalued or undervalued?

    ZBH currently trades at a P/E ratio of 28.45, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if ZBH is fairly priced.

    What is ZBH's P/E ratio?

    ZBH has a price-to-earnings (P/E) ratio of 28.45, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

    What is ZBH's market cap?

    ZBH (Zimmer Biomet Holdings Inc) has a market capitalization of $20.01 billion, making it a mid-cap stock.

    What is ZBH's price to book ratio?

    ZBH trades at a price-to-book (P/B) ratio of 1.57, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

    Similar Investment Decisions

    Explore investment analyses for stocks similar to Zimmer Biomet Holdings Inc

    Explore Categories

    Disclaimer

    This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.